Optic neuritis (ON) is a self-limiting condition caused by inflammation-driven demyelination process affecting the optic nerve. Main clinical features are sudden, unilateral worsening of visual acuity, colour vision disturbance, visual field defects and motion-induced ocular pain. Spontaneous recovery appears usually within up to 8 weeks. It is a frequent initial manifestation of multiple sclerosis. Treatment of optic neuritis remains controversial, although many clinical trials have been conducted to establish firm therapeutic guidelines. The most relevant clinical trial is the Optic Neuritis Treatment Trial (ONTT), proving three days’ intravenous methylprednisolone therapy is not able to change the long-term prognosis, however improving visual recovery, what became a therapeutic option in monocular patients, patients with significant visual field loss, as well as those with professional requirements of fast visual recovery. The ONTT showed that 15-year risk of developing multiple sclerosis was 50 % regardless of the treatment regimen. Oral corticosteroids are recommended for treatment of acute optic neuritis.
Optic neuritis, multiple sclerosis, treatment, corticosteroids, Optic Neuritis Treatment Trial, ONTT
The authors have no conflicts of interest to declare.
Andrzej Grzybowski, Department of Ophthalmology, Poznan City Hospital, 3 Szwajcarska St, 361-285 Poznań,Poland. E: firstname.lastname@example.org
Share this Article
Related Content In Neuro-ophthalmology
Nonorganic Vision Loss
European Ophthalmic Review. 2020;14(1):26–33 DOI: https://doi.org/10.17925/EOR.2020.14.1.26
Nonorganic vision loss (NOVL) or functional vision loss (FVL) is the presence of abnormal vision, or visual fields, without an organic pathology, despite a thorough and comprehensive evaluation. The symptoms will be inconsistent with the results of an objective examination.1–3 In some cases, vision loss is intentionally feigned, while in others it occurs under unconscious conditions. […]
Neuro-ophthalmology in the Geriatric Eye
US Ophthalmic Review. 2020;13(1):30–3 DOI: https://doi.org/10.17925/USOR.2020.13.1.30
As the percentage of elderly people that make up the population of the USA grows, it is imperative to shift our focus on how to best address their needs and outline an approach to the geriatric eye. This review describes common physiologic and pathologic conditions affecting the aging eye including presbyopia, posterior cortical atrophy, giant […]
A Review of Binocular Treatment for Amblyopia
European Ophthalmic Review. 2020;14(1):34–8 DOI: https://doi.org/10.17925/EOR.2020.14.1.34
The term amblyopia, derived from the Greek words α’µβλυ’ς (weak) and ω˛″ψ (eye), is defined as a unilateral (or, less commonly, bilateral) reduction of visual acuity as a result of inadequate visual experience during early life, which leads to a disruption of the normal visual neurodevelopment process.1 It is associated with anisometropia, ametropia, stimulus deprivation, strabismus and nystagmus, and it […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!